ISSN: ISSN: 2329-8790
J. J. Michiels
Goodheart Institute and Foundation,
Anand P Jillella
Director, Bone Marrow/Stem Cell Transplant Program
Georgia Regents University Cancer Center, Augusta, GA , USA
Division of Hematology and Oncology
University of Nebraska Medical center, USA
Submit manuscript at www.longdom.org/submissions/hematology-thromboembolic-diseases.html or send as an e-mail attachment to the Editorial Office at [email protected]
Index Copernicus Value 2015: 62.09
Journal of Hematology & Thromboembolic Diseases is a peer-reviewed medical journal that includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal. The editorial office promises a thorough peer review of the submitted manuscripts to ensure quality.
This is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments as original articles, review articles, case reports, short communications, etc. in the field and provides online access without any restrictions or subscriptions to researchers worldwide.
Journal of Hematology and Thromboembolic Diseases is a peer-reviewed journal, serving the International Scientific Community. This Hematology journal offers an open-access platform to the authors to publish their research outcome.
OMICS International organizes 1000+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ scholarly open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members.
“Hematology and Thromboembolic Diseases” is an open-access journal dedicated to publishing high-quality research in this field. The Journal is a vast repository of Hematological research with a very broad scope. In addition to featuring traditional hematology topics such as Thalassemia, Sickle Cell Disease, Hemolytic Anemia, Rh incompatibility, Myelodysplastic Syndrome, Aplastic Anemia, Spherocytosis, Donor blood/Allo-immunization, embolism, and Von Willebrand's disease, the Journal also features a broad range of ancillary research including, but not restricted to Hematological Oncology, Immunotherapy, AIDS/HIV, Hepatitis C etc.
Every manuscript is subject to the vigorous peer-review process and is approved for publication on the recommendations of distinguished scientists in the field. The published content, therefore, ensures quality and originality. Apart from research articles, the Journal also publishes high-quality Commentaries, Reviews, Case Reports, and Perspectives of pivotal importance. The team at “Hematology and Thromboembolic Diseases” takes immense pride in providing the authors with an efficient and unbiased publishing process.
The journal provides rapid turn-around time for manuscript processing; the advance posting of accepted articles is another advantageous feature. “Hematology and Thromboembolic Diseases” presents an encouraging platform for authors to contribute their valuable findings towards the field.